Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

BUY
$1.07 - $2.95 $328 - $905
307 Added 2.03%
15,421 $16,000
Q4 2022

Feb 10, 2023

BUY
$1.81 - $8.14 $200 - $903
111 Added 0.74%
15,114 $39,000
Q3 2022

Nov 14, 2022

BUY
$6.54 - $9.08 $1,386 - $1,924
212 Added 1.43%
15,003 $105,000
Q2 2022

Aug 12, 2022

BUY
$6.82 - $13.82 $5,953 - $12,064
873 Added 6.27%
14,791 $101,000
Q1 2022

May 13, 2022

SELL
$11.65 - $15.28 $11,428 - $14,989
-981 Reduced 6.58%
13,918 $196,000
Q4 2021

Feb 11, 2022

BUY
$12.37 - $16.77 $75,580 - $102,464
6,110 Added 69.52%
14,899 $216,000
Q3 2021

Nov 12, 2021

BUY
$13.7 - $17.25 $56,567 - $71,225
4,129 Added 88.61%
8,789 $124,000
Q2 2021

Aug 13, 2021

BUY
$13.75 - $18.8 $2,585 - $3,534
188 Added 4.2%
4,660 $82,000
Q1 2021

May 07, 2021

BUY
$11.49 - $19.21 $51,383 - $85,907
4,472 New
4,472 $68,000

Others Institutions Holding BVS

About Bioventus Inc.


  • Ticker BVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 61,664,200
  • Market Cap $659M
  • Description
  • Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...
More about BVS
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.